IN2014DN08922A - - Google Patents
Info
- Publication number
- IN2014DN08922A IN2014DN08922A IN8922DEN2014A IN2014DN08922A IN 2014DN08922 A IN2014DN08922 A IN 2014DN08922A IN 8922DEN2014 A IN8922DEN2014 A IN 8922DEN2014A IN 2014DN08922 A IN2014DN08922 A IN 2014DN08922A
- Authority
- IN
- India
- Prior art keywords
- pyrazine
- difluoromethyl
- action
- hibitory
- chloropyrazine
- Prior art date
Links
- IHYMWNUBROPCOP-UHFFFAOYSA-N 5-(difluoromethyl)pyrazine-2-carboxamide Chemical compound NC(=O)C1=CN=C(C(F)F)C=N1 IHYMWNUBROPCOP-UHFFFAOYSA-N 0.000 abstract 1
- ABKZAJKWQBRNOR-UHFFFAOYSA-N 5-[carboxy(difluoro)methyl]pyrazine-2-carboxylic acid Chemical compound OC(=O)C1=CN=C(C(F)(F)C(O)=O)C=N1 ABKZAJKWQBRNOR-UHFFFAOYSA-N 0.000 abstract 1
- FXJOTWLLDJYKAG-UHFFFAOYSA-N 5-chloropyrazine-2-carboxylic acid Chemical compound OC(=O)C1=CN=C(Cl)C=N1 FXJOTWLLDJYKAG-UHFFFAOYSA-N 0.000 abstract 1
- 102100021257 Beta-secretase 1 Human genes 0.000 abstract 1
- 101000894895 Homo sapiens Beta-secretase 1 Proteins 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000010276 construction Methods 0.000 abstract 1
- 230000000911 decarboxylating effect Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261639362P | 2012-04-27 | 2012-04-27 | |
| PCT/JP2013/062863 WO2013162065A1 (en) | 2012-04-27 | 2013-04-25 | Method for producing 5-(difluoromethyl)pyrazine-2-carboxilic acid and production intermediate thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN08922A true IN2014DN08922A (enExample) | 2015-05-22 |
Family
ID=49483351
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN8922DEN2014 IN2014DN08922A (enExample) | 2012-04-27 | 2013-04-25 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9227942B2 (enExample) |
| EP (1) | EP2841423B1 (enExample) |
| JP (1) | JP6118817B2 (enExample) |
| CN (1) | CN104245680B (enExample) |
| BR (1) | BR112014026474A2 (enExample) |
| CA (1) | CA2871264A1 (enExample) |
| ES (1) | ES2615304T3 (enExample) |
| HU (1) | HUE030534T2 (enExample) |
| IL (1) | IL235161A0 (enExample) |
| IN (1) | IN2014DN08922A (enExample) |
| MX (1) | MX2014012683A (enExample) |
| RU (1) | RU2014142545A (enExample) |
| SG (1) | SG11201406589PA (enExample) |
| WO (1) | WO2013162065A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI639607B (zh) | 2013-06-18 | 2018-11-01 | 美國禮來大藥廠 | Ｂａｃｅ抑制劑 |
| WO2021157591A1 (ja) * | 2020-02-06 | 2021-08-12 | Ａｇｃ株式会社 | 芳香族複素環置換ジフルオロ酢酸誘導体の製造方法 |
| CN112645890B (zh) * | 2020-12-25 | 2022-08-12 | 江苏广域化学有限公司 | 2-吡嗪羧酸酯类化合物的合成方法 |
| CN117897377A (zh) * | 2021-08-11 | 2024-04-16 | Ａｇｃ株式会社 | 使用四氟乙烯进行的杂环的二氟甲基化反应 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090012075A1 (en) | 2006-01-12 | 2009-01-08 | Miller Thomas A | Fluorinated Arylamide Derivatives |
| US20100317850A1 (en) * | 2008-01-18 | 2010-12-16 | Yuichi Suzuki | Condensed aminodihydrothiazine derivative |
| EP2303881A2 (en) | 2008-07-14 | 2011-04-06 | Gilead Sciences, Inc. | Fused heterocyclyc inhibitors of histone deacetylase and/or cyclin-dependent kinases |
| MX2011003189A (es) | 2008-09-30 | 2011-04-27 | Eisai R&D Man Co Ltd | Nuevo derivado de aminodihidrotiazina fusionada. |
| AR077277A1 (es) | 2009-07-09 | 2011-08-17 | Lilly Co Eli | Compuestos de biciclo (1,3)tiazin-2-amina formulacion farmaceutica que lo comprende y su uso para la manufactura de un medicamento util para el tratamiento de la enfermedad de alzheimer |
| GB0912777D0 (en) | 2009-07-22 | 2009-08-26 | Eisai London Res Lab Ltd | Fused aminodihydropyrimidone derivatives |
| GB0912778D0 (en) | 2009-07-22 | 2009-08-26 | Eisai London Res Lab Ltd | Fused aminodihydro-oxazine derivatives |
| JP5696355B2 (ja) | 2009-11-18 | 2015-04-08 | セントラル硝子株式会社 | 芳香族ジフルオロメチル化合物の製造方法 |
| US8673894B2 (en) | 2010-05-07 | 2014-03-18 | Hoffmann-La Roche Inc. | 2,5,6,7-tetrahydro-[1,4]oxazepin-3-ylamine or 2,3,6,7-tetrahydro-[1,4]oxazepin-5-ylamine compounds |
| JP5679855B2 (ja) | 2011-02-14 | 2015-03-04 | 国立大学法人群馬大学 | ジフルオロメチル化ヘテロアリール化合物の製造方法 |
-
2013
- 2013-04-25 IN IN8922DEN2014 patent/IN2014DN08922A/en unknown
- 2013-04-25 RU RU2014142545A patent/RU2014142545A/ru unknown
- 2013-04-25 ES ES13781634.4T patent/ES2615304T3/es active Active
- 2013-04-25 BR BR112014026474A patent/BR112014026474A2/pt not_active Application Discontinuation
- 2013-04-25 US US14/396,261 patent/US9227942B2/en active Active
- 2013-04-25 CN CN201380021262.XA patent/CN104245680B/zh active Active
- 2013-04-25 CA CA2871264A patent/CA2871264A1/en not_active Abandoned
- 2013-04-25 HU HUE13781634A patent/HUE030534T2/hu unknown
- 2013-04-25 JP JP2014547207A patent/JP6118817B2/ja not_active Expired - Fee Related
- 2013-04-25 SG SG11201406589PA patent/SG11201406589PA/en unknown
- 2013-04-25 WO PCT/JP2013/062863 patent/WO2013162065A1/en not_active Ceased
- 2013-04-25 MX MX2014012683A patent/MX2014012683A/es unknown
- 2013-04-25 EP EP13781634.4A patent/EP2841423B1/en active Active
-
2014
- 2014-10-19 IL IL235161A patent/IL235161A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN104245680B (zh) | 2016-11-23 |
| SG11201406589PA (en) | 2014-11-27 |
| CA2871264A1 (en) | 2013-10-31 |
| BR112014026474A2 (pt) | 2017-06-27 |
| ES2615304T3 (es) | 2017-06-06 |
| CN104245680A (zh) | 2014-12-24 |
| EP2841423B1 (en) | 2016-11-30 |
| MX2014012683A (es) | 2015-01-16 |
| US9227942B2 (en) | 2016-01-05 |
| IL235161A0 (en) | 2014-12-31 |
| RU2014142545A (ru) | 2016-06-27 |
| EP2841423A1 (en) | 2015-03-04 |
| WO2013162065A1 (en) | 2013-10-31 |
| JP6118817B2 (ja) | 2017-04-19 |
| US20150087836A1 (en) | 2015-03-26 |
| JP2015514676A (ja) | 2015-05-21 |
| EP2841423A4 (en) | 2015-09-09 |
| HUE030534T2 (hu) | 2017-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY172391A (en) | Processes for preparing dihydropyrimidine derivatives and intermediates thereof | |
| MY182428A (en) | Crystalline forms of a prolyl hydroxylase inhibitor | |
| MX2015005251A (es) | Metodos para producir 5-(halometil)furfural. | |
| WO2010091808A8 (en) | Fused pyrimidines | |
| WO2015008218A3 (en) | Process for the preparation of suvorexant and intermediates useful in the synthesis of suvorexant | |
| EA201270280A1 (ru) | Соединения пиримидина в качестве ингибиторов при лечении туберкулеза | |
| MX2014004920A (es) | Nuevos derivados de pirazina. | |
| CL2011000296A1 (es) | Proceso de preparación del ester metílico del ácido 4-oxo-octahidro-indol-1-carboxílico y compuestos intermediarios utilizados. | |
| MX2015001114A (es) | Metodo para producir 4-[5-(piridin-4-il)-1h-1,2,4-triazol-3-il] piridina-2-carbonitrilo e intermediario del mismo. | |
| Grošelj et al. | α-Amino acid derived enaminones and their application in the synthesis of N-protected methyl 5-substituted-4-hydroxypyrrole-3-carboxylates and other heterocycles | |
| IN2014DN08922A (enExample) | ||
| UA105479C2 (uk) | Спосіб одержання 2-сульфініл-1h-бензоімідазолів | |
| IN2014DN06964A (enExample) | ||
| UA106619C2 (uk) | Спосіб отримання похідних 1-(2-галогенбіфеніл-4-іл)-циклопропанкарбонової кислоти | |
| MX2014004688A (es) | Proceso de obtencion de acidos isoxazolil-metoxi-nicotinicos. | |
| WO2014087208A3 (en) | A process of preparing alcaftadine | |
| MX2016012485A (es) | Proceso para preparar 3-(3-(4-(1-aminociclobutil)fenil)-5-fenil-3h -imidazo[4,5-b]piridin-2-il)piridin-2-amina. | |
| AU2013314244A8 (en) | Novel inhibitor compounds of phosphodiesterase type 10A | |
| WO2014127418A8 (en) | Conjugate compound and uses of same | |
| MY174153A (en) | Processes for the preparation of pyrimidinylcyclopentane compounds | |
| EA038364B9 (ru) | Способ получения гидролизата биомассы с пониженным содержанием солей | |
| MX349985B (es) | Procedimiento de preparación de ésteres de fenilacetil aminoácido espirocíclicos con sustitución cis-alcoxi y derivados de 1h-pirrolidin-2,4-diona espirocicíclicos con sustitución cis-alcoxi. | |
| PH12015501840A1 (en) | Production method of pyridazinone compounds | |
| IN2013CH04635A (enExample) | ||
| MX356231B (es) | Procedimiento multietapa para la preparación de sales de metales alcalinos de ésteres 4-hidroxi-2-oxo-2,5-dihidrofuran-3-carboxílic os específicos. |